The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of testosterone replacement therapy after radical prostatectomy on prostate cancer outcomes.
 
Reith Sarkar
No Relationships to Disclose
 
J Kellogg Parsons
Stock and Other Ownership Interests - Johnson & Johnson; Omega Healthcare Investors; Pfizer; Urigen Pharmaceuticals
Honoraria - Sophiris Bio
Other Relationship - MDxHealth
 
John Paul Einck
No Relationships to Disclose
 
Arno James Mundt
Travel, Accommodations, Expenses - Varian Medical Systems
 
A. Karim Kader
Leadership - SNP Bio
Stock and Other Ownership Interests - SNP Bio
Consulting or Advisory Role - Pelficure
Patents, Royalties, Other Intellectual Property - Patent holder for brachytherapy device, patent pending for prostate cancer genetic screening test
 
Christopher J. Kane
Stock and Other Ownership Interests - SNP Bio
 
Paul Riviere
No Relationships to Disclose
 
Rana R. McKay
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Exelixis; Janssen; Novartis; Tempus
Research Funding - Bayer (Inst); Pfizer (Inst)
 
James Don Murphy
No Relationships to Disclose
 
Brent Shane Rose
No Relationships to Disclose